Navigation Links
New DuPont(TM) Agility(TM) SG Herbicide Offers Wheat Growers Answers to Changing Weed Control Needs
Date:1/8/2008

WILMINGTON, Del., Jan. 8 /PRNewswire-FirstCall/ -- DuPont (NYSE: DD) has received registration approval from the U.S. Environmental Protection Agency for Agility(TM) SG herbicide, a new product designed to provide wheat growers with a better tool for broad spectrum weed control, including ALS resistant species. DuPont(TM) Agility(TM) features four active ingredients and two modes of action in a single formulation to offer convenient, broad spectrum control without the hassles of mixing multiple products.

"Agility(TM) SG is yet another example of how DuPont Crop Protection is reinventing itself with better choices for managing the changing weed control needs of today's farmers," said Jim Collins, vice president and general manager, DuPont Crop Protection. "Just last month, DuPont announced registration of our Enlite(TM) and Envive(TM) herbicides for soybeans, and we expect to launch several new corn herbicides soon. We're building momentum on our strategy to give growers better answers faster than ever before."

Collins said that the Agility(TM) SG herbicide harnesses two patented, proprietary technologies from DuPont: homogeneous blends and DuPont(TM) TotalSol(R) soluble granules. The homogeneous blend technology enables DuPont to rapidly develop new herbicides with multiple active ingredients to respond to changing weed control issues. TotalSol(R) is a new formulation that dissolves completely for more consistent weed control and improved tank cleanout.

Agility(TM) SG controls more than 80 tough broadleaf weeds, including Russian thistle, pigweed and kochia, even ALS resistant species. Agility(TM) SG also is covered by the DuPont(TM) Crop Protection Plus(R) wheat program, which provides growers who purchase qualifying h
'/>"/>

SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Medifast Offers Stranded Pure Weight Loss Clients Unique Options
2. Jenny Craig Offers Help to Stranded Clients
3. The Healthy Monday Movement Offers a Unique New Years Idea to All Americans
4. Research Offers Promise for Cirrhosis Treatment
5. Sams Club Offers Health and Wellness Event Make New Year Resolutions Produce Real Results
6. ASGE offers guidelines on endoscopic treatment of dyspepsia
7. American Lung Association Offers Biodiesel Scholarship to Minnesota High School Seniors
8. With Calorie Counting on Holiday Hiatus, NutriSystem Offers Advanced Resolution for 2008
9. Cipla Offers Modest AIDS Drug Price Cut: Not Nearly Enough, says AHF
10. Fitness Guru Offers Novel Exercise Program and Tips to Stick with Exercise in the New Year
11. New Long-Term Care Insurer Offers Simplified Insurance Plans in Florida
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2008)...y,s sleep-wake system ,can,t remember anything, s... News) -- Your body clock may do more than help gu...y a vital role in learning and memory, say Stanfor...ers, they found that a functioning circadian syste...what they,ve learned. Without it, they "can,t reme...
(Date:10/13/2008)...008 Earnings Conference Call on October 30 - - Pr... Conference on Novemb...estors and Financial Analysts on ...ewswire-FirstCall/ -- Gen-Probe Incorporated,(Nasd...webcast three upcoming,investor events., First, G...
(Date:10/13/2008)...e of six sites included in national study St...rates, OSHKOSH, Wis., Oct. 13 /PRNewswire/ -- Adv...cedcirculatory.com ) announced today that it has,r... the National Institutes,of Health (NIH) to contin...,on those who experience cardiac arrest outside a ...
(Date:10/13/2008)...) Market Leading Content Rights Management System,...p on Their Content Spend, WEST CHESTER, Pa., Oct....that a leading global pharmaceutical manufacturer ...ecome the primary platform for the,secure distribu...ng,analytics for their new product video content. ...
Breaking Medicine News(10 mins):Health News:Circadian Rhythm Plays Role in Memory 2Health News:Gen-Probe Announces Webcasts of Three Upcoming Investor Events 2Health News:Gen-Probe Announces Webcasts of Three Upcoming Investor Events 3Health News:Advanced Circulatory Systems Receives $1.5 Million From NIH for Study of Cardiac Arrest Resuscitation Techniques 2Health News:Global Pharma Integrates Imperium(TM) to Support Launch Content ROI Initiatives! 2
...beer and alcohol increases the risk of colorectal ...the risk, according to a study. // The study, cond...t Stony Brook University, Stony Brook, New York, w...lar alcohol consumption on the detection of signif...
...des are a broad range of user-controlled products ...ally transmitted diseases including AIDS.// It can...e such as a gel, cream, film or suppository. Thes...tiate condom use or to abandon partners who put th...
... Torsten Baldeweg and his colleagues from the Inst... in brain of children’s who were born premature.//...n activity during their life time. The study will ...heir brain which could help to support and assist ...
... subcutaneous tissue, the interstitial fluid press...us tissue of an animal is exposed, fluid does not ... tumor tissue and forms a barrier against efficien...ticancer drugs and antibodies used for treating pa...
Other Medicine News:Health News:Alcohol Drinking Affects Risk Of Colorectal Tumours 2Health News:New Research To Study Brain Changes In Premature Births 2Health News:A Novel Method For Measuring Interstitial Fluid Pressure In Cancer Tissues 2
(Date:10/12/2008)...and WASHINGTON, Oct. 12 /- ...announced results from an analysis,of nearly 7,500..., which,are designed to confirm the performance of...nary Stent System in real-world practice. The,two-...t reduced clinical,restenosis in patients with dia...
(Date:10/10/2008)...Mich., Oct. 10 /- Diplomat Specialty,...s selected Diplomat,Specialty Pharmacy to be one o..., national Therapy Optimization Study for Multiple...OP MS study, is to examine the benefits of a,speci...ance, adherence and,patient outcomes. Targeted pat...
(Date:10/10/2008)..., Oct. 10 /- Inverness Medi...vider of near-patient,diagnostics, monitoring and ...n Ki-moon, the Secretary-General of the United Nat...eventeen of the world,s leading,research-based and...Inverness, together with senior officials from the...
(Date:10/10/2008)...lif., Oct. 10 /- TriReme Medical Inc.... to affix the CE (Conformite,Europeenne) marking a...y,Stent System, a unique main vessel stent system ...urcations., Representing the next generation in b...tential use in a quarter of the 2.2 million,angiop...
Breaking Medicine Technology:TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 2TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 3TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 4TAXUS(R) Express(R) Stent Shows Similarly Low Re-Intervention Rates in Patients With Diabetes Compared to Non-Diabetics in Arrive Registry Program 5Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System 2Leading Childrens Hospital Utilizes MEDais Solutions to Deliver Outstanding Care 4025 1Leading Childrens Hospital Utilizes MEDais Solutions to Deliver Outstanding Care 4025 2Nventa updates progress of cervical dysplasia trial with new HspE7 1339 1Nventa updates progress of cervical dysplasia trial with new HspE7 1339 2Nventa updates progress of cervical dysplasia trial with new HspE7 1339 3Nventa updates progress of cervical dysplasia trial with new HspE7 1339 4Nventa updates progress of cervical dysplasia trial with new HspE7 1339 5Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 1334 1Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 1334 2Nile Therapeutics Appoints Pedro Granadillo to Board of Directors 1334 3FDA Panel Mulls Ban on Kids Cold Medicines 4019 1FDA Panel Mulls Ban on Kids Cold Medicines 4019 2FDA Panel Mulls Ban on Kids Cold Medicines 4019 3FDA Panel Mulls Ban on Kids Cold Medicines 4019 4
... Data presented at the 11th International Myeloma ... activity of perifosine in,combination with bortez...asone, in patients with relapsed/refractory multip... relapsed/refractory,Waldenstrom,s macroglobulinem... -- Keryx,Biopharmaceuticals, Inc. today announced...
... IRVING, Texas--(BUSINESS WIRE)--Jun 29, 2007 - Re...entation of new,preclinical data showing their lea...A 402, is effective at protecting against,common t... This,data was presented at the annual meeting of ...n Cancer (MASSC) in St Gallen,Switzerland., Reata...
Other Medicine Technology:Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 2RTA 402 Shown to Protect Animals Against Toxicities of Standard,Cancer Treatments 3
...ce by physicians in office based electrosurgery fo...e power settings, maintain the sterile field and d... to control the function and output of the Hyfreca...d or safety issue is detected. Cost effective alte...
...ost powerful isolated ESU on the market with 10,00...ows the surgeon to adjust power settings from the ...r Plus PC Patented Controlled Output Voltage in CU...utting through various impedance tissues with mini...
Microprocessor-based isolated electrosurgical generator, designed for all general surgical procedures. Unit includes the Valleylab adaptive REM system and Instant Response technology.
Black multi-pinhole occluder
Medicine Products: